UMIN ID: UMIN000002325
Registered date:11/08/2009
gene profiling study for the efficacy of Trastuzumab
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | breast cancer |
Date of first enrollment | 2009/06/01 |
Target sample size | 60 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | repeatability investigation |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1. patients with brain metastasis 2. patients with massive effusion 3. patinets with sever heart failure and reduced cardiac function caused treatment with trastuzumab 4. patients with pregnancy |
Related Information
Primary Sponsor | National Cancer Center |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | New Energy and Industrial Technology Development Organization |
Secondary ID(s) |
Contact
public contact | |
Name | Chikako Shimizu |
Address | Japan |
Telephone | |
NCC_IRBoffice@ml.res.ncc.go.jp | |
Affiliation | National Cancer Center breast and medical onoclogy |
scientific contact | |
Name | Yasuhiro Fujiwara |
Address | Tsukiji 5-1-1, Chuo-ku, Tokyo, Japan Japan |
Telephone | 03-3542-2511 |
Affiliation | National Cancer Center breast and medical onoclogy division |